A clinical trial to inspect whether varicella zoster virus vaccine inoculation induces antitumor immunity in patients with adult T-cell leukemia / lymphoma

Not Applicable

• Conditions: Adult T-cell leukemia/lymphoma

• Registration Number: JPRN-UMIN000021750
• Lead Sponsor: Japanese Red Cross Nagasaki Genbaku Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-04-04
• Study Completion: 2020-01-17
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up continuing
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

Not provided

Exclusion Criteria

1.In the case of an infectious disease due to a virus belonging to Herpesviridae before inoculation of VZV vaccine after the initiation of chemotherapy for ATLL. 2.In the case that the patient has another active primary cancer. 3.In the case that HBs antigen is positive. 4.In the case that HIV antibody is positive. 5.Women during pregnancy. Women of lactating. 6.In the case that the patient is complicated with psychosis or psychiatric symptoms, and it is judged that the enrollment of the study is difficult. 7.In the case that the patient has a disease, which is not ATLL, with the immunodeficiency or the immunosuppression. In the case that the patient receives an immunosuppressive therapy. 8.In the case that the patient is judged to be unsuitable for a trial entry by the medical attendant.

Study & Design

• Study Type: Interventional
• Study Design: Not specified